Search Results

There are 8156014 results for: content related to: Review article: hyperlipidaemia and cardiovascular risk

  1. You have free access to this content
    Canine hyperlipidaemia

    Journal of Small Animal Practice

    Volume 56, Issue 10, October 2015, Pages: 595–605, P. G. Xenoulis and J. M. Steiner

    Version of Record online : 12 OCT 2015, DOI: 10.1111/jsap.12396

  2. You have free access to this content
    Impact of renal surgery for cortical neoplasms on lipid metabolism

    BJU International

    Volume 114, Issue 6, December 2014, Pages: 837–843, Aditya Bagrodia, Ryan P. Kopp, Reza Mehrazin, Hak J. Lee, Michael A. Liss, Ramzi Jabaji, Christopher J. Kane, Robert W. Wake, Anthony L. Patterson, Jim Y. Wan and Ithaar H. Derweesh

    Version of Record online : 15 JUL 2014, DOI: 10.1111/bju.12744

  3. A prospective case-controlled study of patients presenting with idiopathic sensorineural hearing loss to examine the relationship between hyperlipidaemia and sensorineural hearing loss

    Clinical Otolaryngology & Allied Sciences

    Volume 24, Issue 6, December 1999, Pages: 531–536, N. S. Jones and A. Davis

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2273.1999.00310.x

  4. Hyperlipidaemia and outcome in acute pancreatitis

    International Journal of Clinical Practice

    Volume 60, Issue 2, February 2006, Pages: 156–159, S. Balachandra, 1 I. T. Virlos, 1 N. K. K. King, 1 H. P. P. Siriwardana, 1 M. W. France and 2 A. K. Siriwardena 1

    Version of Record online : 13 DEC 2005, DOI: 10.1111/j.1742-1241.2005.00645.x

  5. Relevance of erythrocyte Na+/Li+ countertransport measurement in essential hypertension, hyperlipidaemia and diabetic nephropathy: a critical review

    European Journal of Clinical Investigation

    Volume 28, Issue 5, May 1998, Pages: 339–352, Van Norren, Thien, Berden, Elving and De Pont

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2362.1998.00302.x

  6. A prospective case-controlled study of 197 men, 50–60 years old, selected at random from a population at risk from hyperlipidaemia to examine the relationship between hyperlipidaemia and sensorineural hearing loss

    Clinical Otolaryngology & Allied Sciences

    Volume 24, Issue 5, October 1999, Pages: 449–456, N. S. Jones and A. Davis

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2273.1999.00294.x

  7. You have free access to this content
    Cavernous smooth muscle hyperplasia in a rat model of hyperlipidaemia-associated erectile dysfunction

    BJU International

    Volume 108, Issue 11, December 2011, Pages: 1866–1872, Xuefeng Qiu, Thomas M. Fandel, Guiting Lin, Yun-Ching Huang, Yu-Tian Dai, Tom F. Lue and Ching-Shwun Lin

    Version of Record online : 2 SEP 2011, DOI: 10.1111/j.1464-410X.2011.10162.x

  8. Hyperlipidaemia—management and views amongst physicians in general practice, in occupational health care and in internal medicine

    Journal of Internal Medicine

    Volume 234, Issue 4, October 1993, Pages: 411–416, B. DANIELSSON and H. ÅBERG

    Version of Record online : 3 AUG 2009, DOI: 10.1111/j.1365-2796.1993.tb00764.x

  9. You have free access to this content
    Hyperlipidaemia induced by a high-cholesterol diet leads to the deterioration of guanosine-3′,5′-cyclic monophosphate/protein kinase G-dependent cardioprotection in rats

    British Journal of Pharmacology

    Volume 158, Issue 6, November 2009, Pages: 1495–1502, Z Giricz, A Görbe, J Pipis, DS Burley, P Ferdinandy and GF Baxter

    Version of Record online : 20 OCT 2009, DOI: 10.1111/j.1476-5381.2009.00424.x

  10. The burden of hyperlipidaemia and diabetes in cardiovascular diseases

    Fundamental & Clinical Pharmacology

    Volume 21, Issue s2, November 2007, Pages: 1–3, Marijan Merkler and Željko Reiner

    Version of Record online : 13 NOV 2007, DOI: 10.1111/j.1472-8206.2007.00529.x

  11. Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia

    Journal of Clinical Periodontology

    Volume 38, Issue 1, January 2011, Pages: 8–16, Özlem Fentoğlu, Banu Kale Köroğlu, Hicran Hiçyılmaz, Tuba Sert, Muhsin Özdem, Recep Sütçü, M. Numan Tamer, Hikmet Orhan, Zuhal Yetkin Ay, Mine Öztürk Tonguç and F. Yeşim Kırzıoğlu

    Version of Record online : 10 NOV 2010, DOI: 10.1111/j.1600-051X.2010.01644.x

  12. Relationship of sFas with metabolic risk factors and their clusters

    European Journal of Clinical Investigation

    Volume 40, Issue 6, June 2010, Pages: 527–533, Akiko Tamakoshi, Koji Suzuki, Yingsong Lin, Yoshinori Ito, Kiyoko Yagyu, Shogo Kikuchi, Yoshiyuki Watanabe, Yutaka Inaba, Kazuo Tajima, Kei Nakachi and for the JACC Study Group

    Version of Record online : 18 MAY 2010, DOI: 10.1111/j.1365-2362.2010.02293.x

  13. Hyperlipidaemia, alcohol abuse and acute pancreatitis

    British Journal of Surgery

    Volume 71, Issue 9, September 1984, Pages: 685–688, A. P. Dickson, J. O. Neill and Mr C. W. Imrie

    Version of Record online : 8 DEC 2005, DOI: 10.1002/bjs.1800710913

  14. Danzhi Qing'e (DZQE) activates AMPK pathway and regulates lipid metabolism in a rat model of perimenopausal hyperlipidaemia

    Experimental Physiology

    Volume 101, Issue 11, 1 November 2016, Pages: 1406–1417, Xiaoxue Xing, Lina Su, Patrick Fordjour Asare, Lingyan Wang, Lan Li, Erwei Liu, Bing Yu, Yan Zhu, Xiumei Gao and Guanwei Fan

    Version of Record online : 31 OCT 2016, DOI: 10.1113/EP085786

  15. Melatonin prevents testicular damage in hyperlipidaemic mice

    Andrologia

    Volume 44, Issue 4, August 2012, Pages: 230–236, K. Zhang, Z. Lv, X. Jia and D. Huang

    Version of Record online : 20 JAN 2012, DOI: 10.1111/j.1439-0272.2012.01272.x

  16. You have free access to this content
    Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation

    British Journal of Clinical Pharmacology

    Volume 55, Issue 3, March 2003, Pages: 288–298, Chen-Chang Yang, Susan S. Jick and Marcia A. Testa

    Version of Record online : 10 MAR 2003, DOI: 10.1046/j.1365-2125.2003.01724.x

  17. Type III hyperlipidaemia with primary hypothyroidism: a unique clinical course of hyperlipidaemia during replacement therapy of thyroid hormone

    Clinical Endocrinology

    Volume 46, Issue 5, May 1997, Pages: 627–630, J. Kobayashi, K. Yamazaki, J. Tashiro, S. Murano, Y. Saito and N. Morisaki

    Version of Record online : 29 OCT 2003, DOI: 10.1046/j.1365-2265.1997.1390964.x

  18. Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia

    European Journal of Clinical Investigation

    Volume 39, Issue 8, August 2009, Pages: 689–698, D. Masuda, Y. Nakagawa-Toyama, K. Nakatani, M. Inagaki, K. Tsubakio-Yamamoto, J. C. Sandoval, T. Ohama, M. Nishida, M. Ishigami and S. Yamashita

    Version of Record online : 27 MAY 2009, DOI: 10.1111/j.1365-2362.2009.02163.x

  19. You have free access to this content
    CD11c+ macrophages and levels of TNF-α and MMP-3 are increased in synovial and adipose tissues of osteoarthritic mice with hyperlipidaemia

    Clinical & Experimental Immunology

    Volume 180, Issue 3, June 2015, Pages: 551–559, K. Uchida, M. Satoh, G. Inoue, K. Onuma, M. Miyagi, K. Iwabuchi and M. Takaso

    Version of Record online : 20 APR 2015, DOI: 10.1111/cei.12607

  20. Influence of apolipoprotein E genotype on the response to caloric restriction in type 2 diabetic patients with hyperlipidaemia

    Diabetes, Obesity and Metabolism

    Volume 5, Issue 5, September 2003, Pages: 345–348, N. Tamasawa, H. Murakami, K. Yamato, J. Matsui, J. Tanabe and T. Suda

    Version of Record online : 27 AUG 2003, DOI: 10.1046/j.1463-1326.2003.00286.x